FDA Generics Office Hopes To Begin Increasing Staff By Year-End
This article was originally published in The Pink Sheet Daily
Executive Summary
To aid in ANDA assignments, OGD is developing a program to prioritize submissions as the agency addresses a 3,000-application backlog, OGD Deputy Director Robert West says during regulatory affairs specialists’ gathering in Seattle.